Besides the six patients with SCN1A variants who could all be classified as having Dravet syndrome, large phenotypic heterogeneity was noted among patients with PRRT2, KCNQ2, and SCN2A variants. This evidence concerns the gene KCNQ2 and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.